Literature DB >> 10644853

Chimeras in noncoding regions between serotypes I and II of segment A of infectious bursal disease virus are viable and show pathogenic phenotype in chickens.

A Schröder1, A A van Loon, D Goovaerts, E Mundt.   

Abstract

Two serotypes, I and II, have been identified for infectious bursal disease virus (IBDV), a member of the family BIRNAVIRIDAE: Here, the generation by reverse genetics of IBDV chimeras in segment A of the bisegmented genome is reported. The 5- and 3'-noncoding regions (NCRs) of a serotype II strain were exchanged with the NCRs of a full-length cDNA clone of segment A of a serotype I strain. Isolated chimeric viruses were characterized in cell culture and susceptible chickens. The results show that IBDV chimeras in segment A were able to replicate in cell culture and that VP1 encoded by a serotype I segment B is functionally active with serotype I NCRs as well as with serotype II NCRs. Chimeric viruses infected susceptible chickens and caused mild depletion of bursal cells. Thus, the noncoding regions of segment A are not responsible for the different pathotypes of IBDV serotypes I and II.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644853     DOI: 10.1099/0022-1317-81-2-533

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus.

Authors:  Tobias Letzel; Fasseli Coulibaly; Felix A Rey; Bernard Delmas; Erik Jagt; Adriaan A M W van Loon; Egbert Mundt
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

2.  Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit.

Authors:  Marina Arnold; Vijay Durairaj; Egbert Mundt; Katja Schulze; Karin D Breunig; Sven-Erik Behrens
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

3.  Different domains of the RNA polymerase of infectious bursal disease virus contribute to virulence.

Authors:  Cyril Le Nouën; Didier Toquin; Hermann Müller; Rüdiger Raue; Katherine M Kean; Patrick Langlois; Martine Cherbonnel; Nicolas Eterradossi
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

4.  Mutations of residues 249 and 256 in VP2 are involved in the replication and virulence of infectious Bursal disease virus.

Authors:  Xiaole Qi; Lizhou Zhang; Yuming Chen; Li Gao; Guan Wu; Liting Qin; Yongqiang Wang; Xiangang Ren; Yulong Gao; Honglei Gao; Xiaomei Wang
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

5.  Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.

Authors:  Wenqian Wang; Yuxin Song; Linlin Liu; Yuan Zhang; Tingting Wang; Wang Zhang; Kai Li; Xiaole Qi; Yulong Gao; Li Gao; Changjun Liu; Yanping Zhang; Yongqiang Wang; Qing Pan; Gaoming He; Xiaomei Wang; Hongyu Cui
Journal:  Microb Cell Fact       Date:  2019-01-31       Impact factor: 5.328

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.